HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned an average rating of “Moderate Buy” from the fourteen research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $110.71.

Several equities research analysts recently issued reports on HQY shares. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Mizuho initiated coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. Bank of America lifted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Royal Bank of Canada increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Finally, JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th.

HealthEquity Stock Down 2.2 %

HealthEquity stock opened at $91.09 on Wednesday. The company has a market capitalization of $7.89 billion, a PE ratio of 83.57, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20. HealthEquity has a fifty-two week low of $62.50 and a fifty-two week high of $105.82. The firm has a 50 day moving average price of $94.28 and a 200 day moving average price of $84.36.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This represents a 13.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 20.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,786 shares of company stock worth $4,140,387 over the last three months. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Hedge funds have recently modified their holdings of the business. International Assets Investment Management LLC acquired a new position in HealthEquity in the 2nd quarter valued at about $35,000. Paladin Wealth LLC acquired a new position in shares of HealthEquity in the third quarter valued at approximately $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of HealthEquity during the second quarter worth approximately $73,000. GAMMA Investing LLC lifted its holdings in shares of HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after purchasing an additional 344 shares during the period. Finally, Quarry LP grew its position in HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after buying an additional 1,089 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.